AC Immune logo

AC Immune

ACIU | NASDAQ
Chart Builder DCF Calculator
$2.09
-$0.04 (-1.88%)
At close: Nov 16, 2026, 4:00 PM ET
$2.09
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.88%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
43.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #425/1021 (Top 42%)

Key Statistics

Market Data

Market Cap $212.71M
1D Range
2.04 2.11
52W Range
2.04 3.70

Valuation (TTM)

PE -4.16
PB 6.60
EV/EBITDA -3.06

Valuation (NTM)

Forward PE 9.34
Forward PEG 0.11
Price Target $7.00
Loading financial charts...

Profile

AC Immune S.A. is a biotech firm operating at the clinical stage, dedicated to pioneering, formulating, and advancing therapeutic agents and diagnostic tools. Its core mission is addressing neurodegen...

Sector Healthcare
Industry Biotechnology
Employees 106
IPO Date Sep 23, 2016
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 4, 2026
EPS
-$0.16
Beat +11.10%
REV
$3.88M
Beat +139.22%
Next Earnings
Mar 12, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$7.00
Upside
+234.93%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.